RxDoctor Payments Data

Andria Ford, MD

Neurology · Saint Louis, MONPI 1316097835

Payments from drug & device makers

What this record shows

Pfizer accounts for 65.4% of it on its own, with 1 other manufacturer making up the rest.

$5,969in general payments, 2019–2025

Across 3 payments — averaging $1989.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Novartis$2K
$1,372,795in research payments, 2019–2025

Across 85 payments — averaging $16,151 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$779K
  • AbbVie$443K
  • Pfizer$141K
  • Abbott$11K

What the payments were for

  • Consulting fees$3,56460%
  • Speaking & faculty fees$2,40540%

General payments by program year

20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$3,905
Novartis1$2,064

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,969 in reported general payments places this provider in the 70th percentile of 381 neurology providers in Missouri.

See all neurology providers in Missouri

Medicare billing

Part B allowed, 2024
$14,735
Medicare patients
62
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin43$467
Atorvastatin Calcium51$323
Amitriptyline Hcl15$267
Losartan Potassium11$125
Metoprolol Succinate12$117
Memantine Hcl14$88
Allopurinol16$78
Lisinopril16$69
Trazodone Hcl11$66
Amlodipine Besylate18$56
Sertraline Hcl12$27

Paid to pharmacies, not to this prescriber.

Other neurology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →